Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
>95
General Information
Version
6
Revision date
2023-10-20
Product name
Polyethylene glycol - 200 grade
Product Synonyms
PEG
CAS No.
25322-68-3
Emergency telephone
(800) 424-9300, 001-703-527-3887
Icons in SDS
Company Information
company name
Fisher Scientific UK
e-mail address of the competent person responsible for the Safety Data Sheet
begel.sdsdesk@thermofisher.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H335
Hazard statements
Code
Statements
H335
May cause respiratory irritation
Section 2
SECTION 2: Hazards identification
CLP Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Classification of the substance or mixture
Physical hazards
Based on available data, the classification criteria are not met
Health hazards
Specific target organ toxicity - (single exposure) Category 3 (H335)
Environmental hazards
Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16
Signal word
Warning
Hazard statements
H335 - May cause respiratory irritation
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P312 - Call a POISON CENTER or doctor if you feel unwell
2.3 Other hazards
Substance is not considered persistent, bioaccumulative and toxic (PBT) / very persistent and very bioaccumulative (vPvB) This product does not contain any known or suspected endocrine disruptors
2.1 Classification of the substance or mixture
CLP Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Physical hazards Based on available data, the classification criteria are not met Health hazards Specific target organ toxicity - (single exposure) Category 3 (H335) Environmental hazards Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16
